Dapsone as an oral corticosteroid sparing agent for asthma

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2002, Pages

  Dewey, Ann ^a   Bara, Anna ^b   Dean, Taraneh P ^a   Walters, E Haydn ^c  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b Medical Unit   (United Kingdom)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ASTHMA; HUMAN; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; DAPSONE; HUMANS;

EID: 84921701816     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003268     Document Type: Article

References (11)

1. Bel E, Barnes N. Other pharmacotherapy. European Respiratory Review 2000;10(69):82-7.
2. Berlow BA, Liebhaber MI, Dyer Z, Spiegel TM. The effect of dapsone in steroid-dependent asthma. Journal of Allergy & Clinical Immunology 1991;87:710-5.
3. Bosch X. Alternative non-steroidal anti-inflammatory therapy for asthma. Immunology Today 1998;19(9):429.
4. Hill JM, Tattersfield AE. Corticosteroid sparing agents in asthma. Thorax 1995;50(5):577-82.
5. Karpel JP, Wait JL. Outpatient management of asthma. Part 6: Alternative anti-inflammatory agents. The Journal of Critical Illness 1999;14(7):377-83.
6. Ledford DK. Treatment of steroid resistant asthma. Immunology & Allergy Clinics of North America 1996;16(4):777-96.
7. Lynch JP, McCune WJ. Immunosuppresive and cytotoxic pharmacotherapy for pulmonary disorders. American Journal of Respiratory & Critical Care Medicine 1997;155(2):395-420.
8. Moss RB. Alternative pharmacotherapies for steroid-dependent asthma. Chest 1995;107(3):817-25.
9. Ruhl R, Halpern GM, Gershwin ME. Unconventional approaches to drug therapy in severe asthma. Allergol et Immunopathology 1993;21(2):53-60.
10. Barnes PJ. Molecular mechanisms of steroid action in asthma. Journal of Allergy & Clinical Immunology 1996;97:168-79.
11. Jadad A, Moore RA, Carroll D, Jenknson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.